JADA 2018-006 JADA vs J-5978

In April 2019 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the powerlifter J-5978 after his sample tested positive for the prohibited substances Boldenone, Clomiphene and Metenolone. After notification the Athlete admitted the violation, waived his right for a hearing, accepted the test result, a provisional suspension and the sanction proposed by JADA.

JADA deems that the Athlete failed to establish that the violation was not intentional, nor how the substances entered his system. Accordingly JADA decides on 7 May 2019 to impose a 4 year period of ineligibility on the Athlete J-5978 starting on the date of the provisional suspension, i.e. 8 April 2019.

Original document

Parameters

Legal Source
National Decisions
Settlement
Date
7 May 2019
Arbitrator
Suzuki, Hidenori
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Settlement
Waiver of "right to be heard"
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Japan Anti-Doping Agency (JADA)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Boldenone
Clomifene
Metenolone
Document type
Pdf file
Date generated
10 July 2019
Date of last modification
15 July 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin